efficacy of oral semaglutide and safety monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind, Phase IIIa, randomised trial Best GLP-1 for Weight Loss:

Single or combination treatments were further performed on patient-derived xenografts (PDXs) from two persons with lung cancer

Its made in the gut and released after we eat

While there was an average reduction in bodyweight, a previous study on nutritional safety following LFD did not find any clinically meaningful changes in in macro- or micronutrient intake in spite of weight loss, indicating its relative safety (21)

(Buhler) [4] Brightseed Launches BioMetaControl, a Nature-Inspired GLP-1 Companion for Metabolic Health (2025): Brightseed, the company unlocking the power of natures bioactives to elevate human health, today announced the commercial debut of BioMetaControl, its first bioactive ingredient